US Pharma MarketingThe findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.
J&J’s Ottava robot meets goals in gastric bypass study
The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.
Source: MedTech Dive